Importantly, PDLIM1 combines with α-actinin-4 to form a PDLIM1-α-actinin complex, thereby promoting the activation of Cdc42, which is a key factor in regulating cell polarity and migration of breast cancer cells [13, 64]. The gene discussed is CDC42; the disease is breast carcinoma.